erythromycin NDC 72162-2075

NDC codes

FDA NDC Directory

Product NDC (as listed)72162-2075Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72162-2075Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72162-2075-6	72162207506	1 BOTTLE in 1 CARTON (72162-2075-6) / 60 mL in 1 BOTTLEMarketed from Aug 16, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): erythromycin
Generic name (nonproprietary): erythromycin
Active ingredients: Erythromycin — 20 mg/mL
Dosage form: Solution
Route: Topical
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 063038
Marketing start: Dec 19, 2011
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Macrolides (Chemical structure)
Identifiers: Product ID 72162-2075_4ddb7356-308f-4c0a-bda1-7c49fb7efe29SPL ID 4ddb7356-308f-4c0a-bda1-7c49fb7efe29SPL set ID 00c4f27e-59e2-4173-99b1-59dd295e83deRxCUI 318202UNII 63937KV33D
Pharmacologic class: Macrolide Antimicrobial; Macrolide

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472162207506 followed by a unit qualifier and the quantity

Package 72162-2075-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 11, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Erythromycin Topical Solution USP, 2% is indicated for the topical treatment of acne vulgaris.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 063038

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 063038
Product	Strength	Form · route	Labeler	Product NDC
erythromycin	Erythromycin 20 mg/mL	SolutionTopical	Padagis Israel Pharmaceuticals Ltd	45802-038
erythromycin	Erythromycin 20 mg/mL	SolutionTopical	NuCare Pharmaceuticals,Inc.	68071-4791